Mopral



Indications and Reactions:

Role Indications Reactions
Primary
Rheumatoid Arthritis 14.1%
Hypertension 9.8%
Gastrooesophageal Reflux Disease 8.5%
Acute Lymphocytic Leukaemia 7.7%
Prophylaxis Against Gastrointestinal Ulcer 6.8%
Prophylaxis 6.4%
Dyspepsia 5.6%
Depression 4.7%
Pain 4.7%
Sciatica 4.7%
Abdominal Pain Upper 4.3%
Diabetes Mellitus 3.0%
Hypercholesterolaemia 3.0%
Anxiety 2.6%
Hiatus Hernia 2.6%
Induction Of Anaesthesia 2.6%
Suicide Attempt 2.6%
Essential Hypertension 2.1%
Multiple Myeloma 2.1%
Obesity 2.1%
Renal Failure Acute 10.5%
Cytolytic Hepatitis 9.3%
Thrombocytopenia 9.3%
Pyrexia 8.1%
Acute Generalised Exanthematous Pustulosis 7.0%
Drug Interaction 5.8%
Drug Rash With Eosinophilia And Systemic Symptoms 5.8%
Urticaria 5.8%
Vomiting 5.8%
Cryptogenic Organising Pneumonia 3.5%
Hyponatraemia 3.5%
Neuropathy Peripheral 3.5%
Pruritus 3.5%
Rhabdomyolysis 3.5%
Tubulointerstitial Nephritis 3.5%
Convulsion 2.3%
Drug Exposure During Pregnancy 2.3%
Drug Reaction With Eosinophilia And Systemic Symptoms 2.3%
Dyspepsia 2.3%
Eosinophilia 2.3%
Secondary
Drug Use For Unknown Indication 38.4%
Product Used For Unknown Indication 11.4%
Rheumatoid Arthritis 5.9%
Hypertension 5.7%
Prophylaxis 5.4%
Unevaluable Event 4.3%
Pain 3.8%
Gastrooesophageal Reflux Disease 3.5%
Acute Lymphocytic Leukaemia 3.3%
Depression 2.4%
Myocardial Infarction 2.4%
Diabetes Mellitus 2.2%
Anxiety 1.7%
Cord Blood Transplant Therapy 1.7%
Abdominal Pain Upper 1.6%
Hypercholesterolaemia 1.3%
Hypothyroidism 1.2%
Infection Prophylaxis 1.2%
Type 2 Diabetes Mellitus 1.2%
Cytomegalovirus Infection 1.1%
Thrombocytopenia 19.0%
Acute Generalised Exanthematous Pustulosis 9.2%
Toxic Skin Eruption 6.5%
Drug Rash With Eosinophilia And Systemic Symptoms 5.9%
Peritoneal Haemorrhage 5.9%
Urinary Retention 5.2%
Agranulocytosis 4.6%
Neutropenia 4.6%
Vomiting 4.6%
Hepatitis 3.9%
Renal Failure Acute 3.9%
Vertigo 3.9%
Condition Aggravated 3.3%
Cytolytic Hepatitis 3.3%
Urine Amylase Increased 3.3%
Hyponatraemia 2.6%
Pyrexia 2.6%
Sepsis 2.6%
Tachycardia 2.6%
Thrombotic Microangiopathy 2.6%
Concomitant
Drug Use For Unknown Indication 35.1%
Product Used For Unknown Indication 21.9%
Hypertension 6.7%
Rheumatoid Arthritis 5.9%
Prophylaxis 4.5%
Hiv Infection 3.3%
Pain 3.0%
Renal Transplant 1.8%
Acute Myeloid Leukaemia 1.7%
Osteoporosis 1.7%
Unevaluable Event 1.7%
Depression 1.7%
Premedication 1.6%
Ill-defined Disorder 1.5%
Acute Lymphocytic Leukaemia 1.5%
Atrial Fibrillation 1.5%
Multiple Myeloma 1.4%
Dyslipidaemia 1.2%
Breast Cancer 1.2%
Insomnia 1.2%
Renal Failure Acute 13.4%
Thrombocytopenia 12.4%
Pyrexia 6.7%
Renal Failure 6.7%
Vomiting 6.7%
General Physical Health Deterioration 5.0%
Rhabdomyolysis 5.0%
Lung Disorder 4.7%
Pulmonary Embolism 4.5%
Toxic Skin Eruption 4.2%
Weight Decreased 4.0%
Pancreatitis Acute 3.7%
Malaise 3.2%
Orthostatic Hypotension 3.0%
Somnolence 3.0%
Transaminases Increased 3.0%
Weight Increased 3.0%
Tachycardia 2.7%
Cytolytic Hepatitis 2.5%
Neutropenia 2.5%
Interacting
Drug Use For Unknown Indication 28.3%
Hypertension 13.0%
Product Used For Unknown Indication 10.9%
Pain 8.7%
Major Depression 4.3%
Musculoskeletal Pain 4.3%
Agitation 2.2%
Atrial Fibrillation 2.2%
Breast Cancer 2.2%
Cardiac Failure 2.2%
Chronic Myeloid Leukaemia 2.2%
Cryptogenic Organising Pneumonia 2.2%
Depression 2.2%
Gastric Disorder 2.2%
Gastric Ulcer 2.2%
Hypercholesterolaemia 2.2%
Myocardial Infarction 2.2%
Prophylaxis 2.2%
Prophylaxis Against Gastrointestinal Ulcer 2.2%
Stent Placement 2.2%
Hypotension 12.5%
Myocardial Infarction 12.5%
Deep Vein Thrombosis 6.3%
Drug Interaction 6.3%
Inappropriate Antidiuretic Hormone Secretion 6.3%
Overdose 6.3%
Pneumonia Aspiration 6.3%
Pulmonary Embolism 6.3%
Road Traffic Accident 6.3%
Tachycardia 6.3%
Thrombocytopenia 6.3%
Thrombosis 6.3%
Traumatic Haematoma 6.3%
Wrong Drug Administered 6.3%